Investment Rating - The report assigns a "Buy" rating to the company, indicating an expected relative price increase of over 15% compared to the CSI 300 index in the next six months [6][12]. Core Views - The company is experiencing pressure on performance due to low industry sentiment, with a slight revenue increase of 2.41% year-on-year to CNY 26.931 billion in 2024, while net profit decreased by 10.43% to CNY 2.220 billion [4][6]. - The company is focusing on both vertical integration and product expansion, with ongoing capacity expansion in spandex and investments in key raw material projects [5][6]. Summary by Sections Financial Performance - In 2024, the company reported revenue of CNY 26.931 billion, a year-on-year increase of 2.41%, and a net profit of CNY 2.220 billion, a decline of 10.43% [4][8]. - The fourth quarter of 2024 saw revenue of CNY 6.559 billion, down 0.87% year-on-year, and a net profit of CNY 205 million, down 62.66% year-on-year [4]. Product and Market Analysis - The spandex industry continues to operate at the bottom of the cycle, facing pressures from concentrated capacity release and weak demand, leading to declining product prices [4]. - The company achieved a spandex sales volume of 368,200 tons (+12.29%) and revenue of CNY 9.051 billion (-2.74%) in 2024 [4]. - The chemical fiber segment's gross margin improved by 1.16 percentage points to 13.66% despite revenue decline [4]. Strategic Initiatives - The company is expanding its spandex capacity with a 150,000-ton project in Chongqing, adjusting its original plan to 250,000 tons and delaying full production to the end of 2026 [5]. - The company is also investing in a 250,000-ton/year BDO and a 240,000-ton/year PTMEG project to stabilize raw material supply and reduce costs [5]. - A planned acquisition of 100% equity in Zhejiang Huafeng Synthetic Resin Co., Ltd. and Zhejiang Huafeng Thermoplastic Polyurethane Co., Ltd. aims to enhance product lines and competitive synergy [5]. Earnings Forecast - The company forecasts earnings per share (EPS) of CNY 0.45 in 2024, increasing to CNY 0.50 in 2025, CNY 0.67 in 2026, and CNY 0.76 in 2027 [6][8].
华峰化学(002064):行业低景气度导致业绩承压,产业链延伸与产品拓展并进